About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Medications That Block Folic Acid During Pregnancy Increase Risk Of Birth Defects

by Aruna on October 16, 2009 at 10:00 AM
Font : A-A+

Medications That Block Folic Acid During Pregnancy Increase Risk Of Birth Defects

Taking medications that reduce or block the actions of folic acid during the first trimester of pregnancy increase the risk that the growing baby will develop abnormalities.

The study was conducted by researchers at Ben-Gurion University of the Negev.

Advertisement

For the study, the researchers obtained medication data from pregnant mothers registered at Clalit HMO, Southern District, and drew information from 84,832 babies born at Soroka University Medical Center in Beer-Sheva, Israel.

"After studying the data, we concluded that first trimester exposure to folic acid antagonists is associated with increased risk for neural tube, cardiovascular and urinary tract defects," said principal investigator Dr. Rafael Gorodischer, professor emeritus at Ben-Gurion University of the Negev.
Advertisement

Healthcare professionals now encourage women to take folic acid supplements or eat food fortified with folic acid if they are planning to get pregnant, as well as during early pregnancy because there is clear evidence that this reduces the risk of any resulting baby having neural tube defects and possibly other birth defects (congenital malformations).

The researchers considered the effects of two groups of medications on pregnancy. Each group consists of drugs that prevent folic acid working in the body.

One group (dihydrofolate reductase inhibitors) prevents folate from being converted into its active metabolites and includes trimethoprim (antibiotic), sulfasalazine (for ulcerative colitis) and methotrexate (chemotherapeutic).

The other medications are known to lower serum and tissue concentrations of folate by various mechanisms, and include antiepileptics (carbamazepine, phenytoin, lamotrigine, primidone, valproic acid and phenobarbital) and cholestyramine (reduces cholesterol).

Dr. Amalia Levy, an epidemiologist with the BGU Faculty of Health Sciences and chair of the BeMORE collaboration, said: "The study shows that exposure to folic acid antagonist in the first trimester of pregnancy more than doubles the risk of congenital malformations in the fetus, and that neural tube defects, such as spina bifida and malformations of the brain, increase by more than six-fold after exposure to these antagonists."

The study just published in the British Journal of Clinical Pharmacology.

Source: ANI
ARU
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
Test Your Knowledge on Lung Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Birth Defect - Genetic Birth Defects Birth defects - Infections Multifactorial Birth Defects Trimester of pregnancy Pregnancy and Exercise Home Pregnancy Test Pregnancy Psychological Changes In Pregnancy 

Most Popular on Medindia

Nutam (400mg) (Piracetam) Noscaphene (Noscapine) Iron Intake Calculator Indian Medical Journals Sinopril (2mg) (Lacidipine) Selfie Addiction Calculator The Essence of Yoga Vent Forte (Theophylline) Post-Nasal Drip Color Blindness Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use